Bill
A 1838
Establishes New Jersey Active Pharmaceutical Ingredient Regulatory Commission.
2024-2025 Regular Session
Introduced by Jessica Ramirez and 1 co-sponsor
New Jersey establishes a dedicated regulatory commission to oversee active pharmaceutical ingredient safety, quality standards, and supply chain integrity within the state.
Introduced in the Assembly, Referred to Assembly Health Committee